OVERVIEW
Gastroesophageal reflux disease (GERD) is a highly prevalent, chronic gastrointestinal disorder that can result in serious complications if undertreated. Proton pump inhibitors (PPIs), the mainstay of GERD treatment, are generally safe and effective. However, some patients undergo PPI therapy for years but have recurrent or refractory symptoms. A new class of acid-suppressing therapies is in late-stage clinical development and nearing approval. In this live, interactive townhall, expert faculty will discuss the latest evidence regarding the diagnosis and management of GERD and erosive esophagitis (EE), including new medical therapies. Faculty will use patient cases to contextualize clinical information on GERD diagnosis and management that learners can apply in their own practices.
GOAL STATEMENT
The goal of this activity is that learners will be better able to diagnose and treat GERD in their practices and improve their understanding of how emerging acid-suppressing therapies may be incorporated into evidence-based care for their patients, when available.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the: [LIST] [ITEM]Endoscopic findings of non-EE vs EE [ITEM]Efficacy and safety data of potassium-competitive acid blockers (P-CABs) for the treatment of EE[/LIST] Have greater competence related to: [LIST] [ITEM]Selecting evidence-based treatment for patients with EE[/LIST]
ACCREDITATION STATEMENT
[JALOGO][MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Fairmont Waterfront
Room: Waterfront Ballroom C
900 Canada Pl
Vancouver, BC V6C 3L5
Canada
This event is neither sponsored by nor endorsed by ACG.
Supported by an independent educational grant from [bold]Phathom Pharmaceuticals[/bold]